Use this url to cite publication: https://hdl.handle.net/20.500.12512/79488
Efficacy and Tolerability of Topiramate
Type of publication
Tezės Web of Science duomenų bazėje / Theses in Web of Science database (T1a1)
Author(s)
| Author | Affiliation |
|---|---|
Title
Efficacy and Tolerability of Topiramate
M. Endziniene, N. Vaiciene, G. Jurkeviciene, J. Grigoniene, L. Gumbeleviciute, L. Lukosiute
Publisher (trusted)
Is Referenced by
Date Issued
| Date |
|---|
2005-08-28 |
Extent
p. 238, abstract no. p703.
Is part of
Epilepsia : abstracts from the 26th International Epilepsy Congress in Paris 26th IEC proceedings : Paris, France, August 28th– September 1st 2005 / guest editors: Alexis Arzimanoglou, Philippe Ryvlin; Interanational League Against Epilepsy, International Bureau for Epilepsy. Malden, MA : Blackwell Science., 2005, vol. 46, suppl. 6.
Version
Originalus / Original
Series/Report no.
Poster session - Paediatric epileptology
Field of Science
Abstract (en)
Purpose: To investigate the efficacy and tolerability of topiramate (TPM) in refractory childhood epilepsy. Methods: The information about the effects of TPM was collected with the help of a questionnaire filled in by the parents of 66 children with refractory epilepsy. Clinical data were retrieved from medical charts of the patients at Kaunas University Hospital. Results: Mean duration of epilepsy was 64.3 months. Positive effects were observed in 53 (80.3%) cases, with more than 50% seizure reduction in 64%; in 20% it was temporary. [...].
Type of document
type::text::conference output::conference proceedings::conference paper
ISSN (of the container)
0013-9580
Other Identifier(s)
(LSMU ALMA)990000652670107106
Coverage Spatial
Jungtinės Amerikos Valstijos / United States of America (US)
Language
Anglų / English (en)
Affiliation(s)